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Background  and  aims:  Simpliﬁed  vaccine  preparation  steps  would  save  time  and  reduce  potential  immun-
isation  errors.  The  aim  of the study  was  to  assess  vaccine  preparation  time  with  fully-liquid  hexavalent
vaccine  (DTaP-IPV-HB-PRP-T,  Sanoﬁ  Pasteur  MSD) versus  non-fully  liquid  hexavalent  vaccine  that  needs
reconstitution  (DTPa-HBV-IPV/Hib,  GlaxoSmithKline  Biologicals).
Methods:  Ninety-six  Health  Care  Professionals  (HCPs)  participated  in  a randomised,  cross-over,  open-
label,  time  and  motion  study  in  Belgium  (2014).  HCPs  prepared  each  vaccine  in  a cross-over  manner  with  a
wash-out  period  of  3–5  min.  An independent  nurse  assessed  preparation  time  and  immunisation  errors  by
systematic  review  of  the  videos.  HCPs  satisfaction  and  preference  were  evaluated  by a self-administered
questionnaire.
Results:  Average  preparation  time  was  36 s for the  fully-liquid  vaccine  and  70.5  s  for  the  non-fully  liquid
vaccine.  The  time  saved  using  the  fully-liquid  vaccine  was  34.5  s (p ≤ 0.001).  On  192 preparations,  57
immunisation  errors  occurred:  47 in  the  non-fully  liquid  vaccine  group  (including  one  missing  reconsti-
tution  of  Hib  component),  10 in the  fully-liquid  vaccine  group.  71.9%  of  HCPs  were  very or  somewhat
satisﬁed  with  the  ease  of  handling  of  both  vaccines;  66.7%  and 67.7%  were  very  or somewhat  satisﬁed
with  speed  of  preparation  in  the  fully-liquid  vaccine  and the  non-fully  liquid  vaccine  groups,  respectively.
Almost  all  HCPs  (97.6%)  stated  they  would  prefer  the  use of  the  fully-liquid  vaccine  in their daily  practice.
Conclusions:  Preparation  of  a fully-liquid  hexavalent  vaccine  can  be completed  in  half  the  time  necessary
to prepare  a  non-fully  liquid  vaccine.  The  simplicity  of  the fully-liquid  hexavalent  vaccine  preparation
helps  optimise  reduction  of immunisation  errors.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Combination vaccines have several beneﬁts for the vaccine, the
hysician, the society, the healthcare system and public health. By
elivering more antigens in fewer injections, combination vaccines
an provide better coverage and timeliness of vaccination, improve
he efﬁciency of the programme and reduce costs for the healthcare
ystem [1].Time spent by Health Care Professionals (HCPs) during vac-
ine preparation is a component of the overall programmatic
ost associated with vaccine administration. Even if limited for
∗ Corresponding author. Tel.: +32 3 2652676.
E-mail address: ilse.decoster@uantwerpen.be (I. De Coster).
ttp://dx.doi.org/10.1016/j.vaccine.2015.06.030
264-410X/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article 
/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
one vaccination (approximately 25% of the overall vaccination
time [2]), this time can be decreased by adapting devices and
may have a larger impact when applied to large populations. For
instance, vaccines could be administered 37.3 s quicker using pre-
ﬁlled syringes compared to multidose vials [3] and 46 s quicker
using a fully-liquid DTP-HepB-Hib combination vaccine1 com-
pared to a non-fully liquid combination vaccine comprising of one
vial of liquid DTwP–HepB and one vial of lyophilised Hib requir-
ing reconstitution2 [2]. Another important aspect for success of
immunisation programmes is the quality with which vaccines
are administered [4]. Proper vaccine handling and preparation is
1 Trade name: Easyﬁve® .
2 Trade names: Tritanrix® and Hiberix® .
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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ritical in maintaining the integrity of the vaccine during transfer
rom the manufacturer’s vial to the syringe and ultimately to the
atient. Guidelines have been developed to assist HCPs in following
p-to-date immunisation standards [5,6]. In Belgium, the National
mmunisation Technical Advisory Group (NITAG) provides recom-
endations for vaccination; based on the NITAG recommendations,
egional Advisory Groups (e.g. the Flemish Vaccination Platform)
etermine the yearly immunisation vaccination schedule. Practical
mmunisation trainings are offered in some medical and paramed-
cal curricula. However, in-service training is only offered to the
ersonnel of well-baby clinics and school health centres. Adapt-
ng devices can contribute to avoid, reduce or mitigate errors in
mmunisation and associated impact on safety [7].
A hexavalent vaccine (DTPa-HBV-IPV/Hib, GlaxoSmithKline
iologicals3), supplied as powder and suspension for reconstitu-
ion and indicated for primary and booster vaccination of infants
gainst diphtheria (D), tetanus (T), pertussis (aP), hepatitis B (Hep
), poliomyelitis (IPV) and disease caused by Haemophilus inﬂuen-
ae type b (Hib) has been available in Europe for over a decade.
yophilised Hib-PRT-T is reconstituted with a syringe containing
he D, T, aP, IPV and Hep B components used as a diluent.
In 2013, a fully-liquid (preﬁlled syringe), ready-to-use hexa-
alent vaccine (DTaP-IPV-HB-PRP-T, Sanoﬁ Pasteur MSD4) was
ranted marketing authorisation in Europe. This vaccine is indi-
ated for primary and booster vaccination of infants and toddlers
rom 6 weeks to 24 months of age against diphtheria, tetanus, per-
ussis, hepatitis B, poliomyelitis and invasive diseases caused by
ib. At the time of this study only the non-fully liquid combination
accine was available in Belgium.
Time and motion studies (T&M) require an independent and
ontinuous observation and are, as such, a more precise method
han self-reporting or work sampling techniques, which collects
ata at intervals of time. In medical care, T&M studies are efﬁ-
iently used to determine the timing and duration of tasks or
rocedures [8]. T&M studies are generally small due to the high
esource demands of conducting independent and continuous ﬁeld
bservations. This can potentially exacerbate an effect of observer
iases and imposes a higher requirement on both subject-selection
nd subject-observer assignment. Furthermore, a change in subject
ehaviour may  occur following the continuous observation of that
ubject performing a task. Methods have been developed to limit
he potential effect of these biases. Recording HCPs’ activities on
ideo has recently been used to prevent the observer effect [9,10]
nd can also allow the observer to replay each and every task for
eview and analysis, thus improving the quality of data.
Using a T&M study design, the main objective of this study was to
ssess vaccine preparation time of fully-liquid hexavalent vaccine
ersus non-fully liquid hexavalent vaccine that requires reconsti-
ution prior to administration. The study also assessed the risk of
mmunisation errors, the satisfaction and preference of HCPs in
harge of paediatric vaccination when using both vaccines.
. Methods
.1. Study design
The study was a cross-over, randomised, open-label study con-
ucted in 4 different cities in Belgium: Brussels, Liège, Charleroi
nd Namur (Fig. 1).Study participants were required to prepare consecutively a
ully-liquid as well as a non-fully liquid vaccine (or in the oppo-
ite order), with at least a 3 to 5 min  wash-out period between
3 Trade name: Infanrix® hexa.
4 Trade name: Hexaxim®/Hexyon®/Hexacima® .3 (2015) 3976–3982 3977
preparations. Vaccines were displayed on a tray along with an asep-
sis set to be used at HCPs’ discretion in accordance with their usual
practice. The ﬁrst vaccine to be prepared was  randomly determined.
Randomisation was stratiﬁed by site and balanced every two par-
ticipants.
Both vaccine preparations were recorded using video equip-
ment allowing for time capture. Immediately after preparation of
both vaccines, HCPs were asked to complete a self-administered
questionnaire on their preference and satisfaction regarding the
two vaccines.
2.2. Participants
In order to reﬂect usual practice in Belgium and different user
proﬁles, HCPs recruited in the study were a combination of Gen-
eral Practitioners (GPs), paediatricians, youth health doctors and
nurses. They had to have more than 2 years of experience in paedi-
atric vaccination and to administer or prepare at least 3 childhood
vaccines per week, including at least one hexavalent vaccine. Prior
speciﬁc training on vaccine preparation and administration was
collected for analysis purposes but were not a pre-requisite for par-
ticipation in the study. HCPs having a permanent position within
pharmaceutical industry or refusing video capture were excluded.
Phone book lists were used to contact HCPs of different special-
ties in the geographical area of cities concerned by the study.
2.3. Setting and bias control
Bias prevention steps included:
• Development of standard scripts for study presentation to the
participants to decrease selection bias. The sponsor name was
systematically concealed until the end of the study procedures.
• A cross-over design to neutralise the effect of video/observer
presence between vaccine preparations.
• On-site study personnel trained to avoid any inﬂuence on HCPs
during vaccine preparation processes.
• Deﬁned start and stop of vaccine preparation time.
• Randomisation of the vaccine preparation sequence and the order
of questions on the self-administered questionnaire.
• Study execution outside the usual HCPs working premises, in a
central location of each city to provide a neutral unity of place,
time and action.
• Vaccine preparation time assessment in a short period of time to
prevent time-effect bias.
• Presentation of both vaccines outside their packaging and with-
out leaﬂet. Thus, avoiding any impact on preparation time due
to potential HCP distraction towards packaging leaﬂets of an
unknown vaccine (the fully-liquid vaccine was  not yet marketed
in Belgium at time of study conduct).
Given the cross-over design of the study and in order to take
into account real life conditions of use (including different levels of
experience), representativeness or homogeneity of the HCP sample
was not required.
2.4. Outcome measures and data collection
2.4.1. Vaccine preparation
An independent HCP (nurse) was trained to assess the time
taken for vaccine preparation and immunisation errors by review-
ing the videos recorded during each assessment. Training included
study methods and video review processes. A physician performed
data quality control by reviewing a random sample of 10% of
the videos. The quality control concerned preparation time and
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mmunisation errors identiﬁcation as well as any issue identiﬁed
y the nurse.
.4.1.1. Vaccine preparation time. Vaccine preparation time was
eﬁned as the period of time between when HCP ﬁrst touched the
aterials on the experimental ﬁeld (e.g. syringe, vial or needles)
nd when he landed down the syringe ready for administration.
t excluded the time necessary to obtain vaccine from storage,
dministration of vaccine, disposal of vial, syringe, needle, and doc-
mentation of vaccine administration. To validate and harmonise
isual references for start and stop of vaccine preparations and
dentiﬁcation of immunisation errors, the ﬁrst 10% of the videos
ere reviewed twice, ﬁrst by the nurse and then by the physician.
inutes and seconds (s) were recorded.
.4.1.2. Immunisation errors. Immunisation errors were deﬁned as:
sepsis fault, needle stick, liquid leakage, failure to purge syringe by
he end of preparation process, missed reconstitution of Hib-PRP-T
non-fully liquid vaccine only), failure to draw up the entire content
f Hib-PRP-T vial in the syringe (non-fully liquid vaccine only). Any
ther unexpected immunisation errors/incidents observed during
accine preparation were also recorded.
.4.2. HCPs satisfaction and preference
Satisfaction with vaccine ease-of-handling and speed of
reparation was collected using a 5-point Likert scale (very
atisﬁed/somewhat satisﬁed/neutral/not very satisﬁed/not at all
atisﬁed). HCPs were then asked to indicate between the two
exavalent-vaccine forms the one they would prefer to use in their
hildhood vaccination daily practice.
.5. Ethics, data privacy and pharmacovigilance
The study was approved by the ethics committee of University
ospital Antwerpen, Belgium.
In this study, vaccines were not administered to patients and
o health data were collected. All data collected were managed in
ccordance with local data privacy regulations.
Written informed consent was obtained from each HCP prior to
tudy start.
A reporting process for potential adverse events or incidents
elated to study vaccines or in relation with their handling during
reparation was established prior to study start.
.6. StatisticsPreviously published data demonstrated an approximately 50%
ecrease in time necessary to prepare a fully liquid vaccine (36 s)
ompared to a lyophilised one (75 s) [2]. Considering a paired test
nd under the assumption of a standard deviation (SD) of 75, 77s of HCP specialty; combining different levels of experience.
HCPs were estimated to be sufﬁcient to demonstrate highly sig-
niﬁcant difference of 50% of time savings with a power of 90%
and a level of signiﬁcance of 0.01. It was  decided prior to study
implementation to include a sample of 100 HCPs to maintain the
possibility, depending on the SD value, of discussing study results
on HCP specialty and number of weekly vaccination.
Differences in time of vaccine preparation were assessed by a
Wilcoxon paired test.
Data were entered using ClinInfo® (Lyon, France) and data anal-
ysis was performed in SAS® software version 9.2 (SAS Institute Inc.,
Cary, USA).
3. Results
3.1. Study sample
Of the 100 HCPs who agreed to participate, 96 HCPs came to the
study site. All HCPs completed the experiment and the question-
naire.
The mean (SD) age of HCPs was 44.5 years (12.7) (Table 1). Of
the 96 HCPs, 50 (52.1%) were paediatricians, 34 (35.4%) were GPs
and 12 (12.5%) were nurses. Besides, 54 (56.3%) performed at least
10 vaccinations (childhood or adult) per week, the remaining 42
(43.8%) performed less than 10 vaccinations in a week; 16 HCPs
worked in Belgian well-baby clinics.
3.2. HCPs practice
Of the 96 HCPs, 32 (33.3%) had previously received speciﬁc train-
ing on vaccine preparation and administration. The highest rates for
speciﬁc training on vaccine preparation and administration were
observed in nurses (8 nurses; 66.7%) and in HCPs who  administered
at least 10 vaccines per week (22 HCPs; 40.7%).
Almost all HCPs (95 HCPs, 99.0%) were typically involved in vac-
cine preparation and administration and 87 (90.6%) were typically
involved in vaccine documentation. These results showed that,
overall, HCPs were involved in the whole vaccination process. One
nurse was not involved in vaccine administration and 9 GPs were
not involved in documentation during the vaccination process.
Twelve HCPs (12.5%) had previously used a fully-liquid hexa-
valent vaccine.
HCPs had delivered paediatric vaccinations for a mean (SD) 17.2
years (12.3), delivering (preparation and/or administration) a mean
(SD) of 16.1 vaccinations (15.7) per week. Among the delivered vac-
cinations, a mean (SD) of 15.3 vaccinations (15.9) were childhood
vaccinations and among these, 8.8 (9.9) were hexavalent vaccina-
tions (Table 2).
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Table  1
Characteristics of the HCPs.
Specialty Number of vaccinationsa Total (N = 96)
Nurses (N = 12) Paediatricians (N = 50) GPs (N = 34) <10 (N = 42) ≥10 (N = 54)
Age (years)
Mean (SD) 43.4 (10.1) 50.0 (11.8) 36.9 (10.8) 40.0 (11.3) 48.1 (12.7) 44.5 (12.7)
Min;  Max  28; 56 26; 73 27; 70 27; 70 26; 73 26; 73
Gender (%)
38.2 
61.8 
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DMale 0.0 36.0 
Female 100.0 64.0 
a Average number of vaccinations performed by HCPs in a week.
.3. Vaccine preparation time
The mean time (SD) needed to prepare the fully-liquid vaccine
as 36.0 s (22.8) and the mean time (SD) needed to prepare the
on-fully liquid vaccine was 70.5 s (33.2) (Fig. 2). The preparation-
ime difference between the two vaccines, i.e. the time saved with
he fully-liquid vaccine, was 34.5 s [95% Conﬁdence Interval (CI):
8.4; 40.6], p < 0.001. This difference was highest among GPs (46.3 s
95%CI: 30.9; 61.7]) and HCPs who performed less than 10 vacci-
ations per week (45.2 s [95%CI: 33.1; 57.3]). The time saving was
tatistically signiﬁcant for the total HCP population, as well as for
ach subgroup studied (Table 3).
.4. Immunisation errors
Overall, 57 immunisation errors were observed during the 192
accine preparations: 47 occurred with the non-fully liquid vaccine
ersus 10 with the fully-liquid vaccine (Table 4a–b). Mean differ-
nce in number of preparation mistakes was 0.39 (95%CI: 0.24;
.53], p < 0.001).
With the non-fully liquid vaccine, mean (SD) number of immun-
sation errors tended to be higher in HCPs performing <10 than
n HCPs performing ≥10 vaccinations per week with respectively
.6 (0.7) vs. 0.4 (0.7) immunisation errors. Mean (SD) number of
mmunisation errors also tended to differ by HCP specialty: 0.3
0.5) in nurses, 0.5 (0.6) in paediatricians and 0.6 (0.8) in GPs. With
he fully-liquid vaccine, no difference was observed by number of
accination performed per week; however, mean (SD) number of
mmunisation errors tended to be lower in paediatricians and GPs
ompared to nurses (respectively 0.1 (0.3) and 0.1 (0.2) vs. 0.3 (0.5))
Table 4a).The most frequently observed immunisation errors during
reparation of the non-fully liquid vaccine were: lack of purge
f syringe by the end of preparation (12 HCPs, 12.5%), syringe
urged before using the second needle (11 HCPs; 11.5%), lack of
able 2
escription of HCP experience in paediatric vaccination in total, by HCP specialty and by 
Specialty 
Nurses (N = 12) Paediatr
Numbers of years in practice in paediatric vaccinations
Mean (SD) 17.3 (10.2) 21.9 (12
Min;  Max  3; 34 2; 46 
Number of vaccinations (preparation and/or
administration) personally managed a week
Mean (SD) 15.3 (10.9) 21.3 (18
Min;  Max  4; 40 1; 75 
Childhood vaccinations
Mean (SD) 15.3 (10.9) 21.1 (18
Min;  Max  4; 40 1; 75 
Hexavalent vaccinations
Mean (SD) 8.6 (5.6) 12.3 (11
Min;  Max  3; 20 1; 55 
a Average number of vaccinations performed by HCPs in a week.35.7 29.6 32.3
64.3 70.4 67.7
replacement of the preparation needle by the administration nee-
dle at the end of vaccine preparation (8 HCPs, 8.3%) and the whole
content of the Hib-PRP-T vial not aspired into the syringe (8 HCPs,
8.3%). In one case reconstitution of the content of the Hib-PRP-T
vial was missed.
The most frequently observed error during preparation of the
fully-liquid vaccine was: lack of purge of the syringe by the end of
preparation (4 HCPs; 4.2%) (Table 4a–b).
Leakage of the non-fully liquid vaccine with skin contact but
without any clinical consequence to the HCP was reported as an
adverse event during the study.
3.5. HCPs satisfaction and preference
Sixty-nine HCPs (71.9%) were very or somewhat satisﬁed with
ease of handlings of both vaccines; 64 HCPs (66.7%) and 65 HCPs
(67.7%) were very or somewhat satisﬁed with speed of prepara-
tion of the fully-liquid vaccine and the non-fully liquid vaccine,
respectively.
Among the 96 HCPs, preference for the vaccine form in child-
hood vaccination daily practice was  assessed in 83 HCPs deemed
to have sufﬁcient experience in childhood vaccination (> 3 vacci-
nations a week). Almost all (97.6%) stated that they would prefer
the use of a fully-liquid hexavalent vaccine in their daily practice.
4. Discussion
4.1. Vaccine preparation time
As expected, and consistently with previous results obtained in a
clinical study conducted in HCPs working environment [2], prepa-
ration of the fully-liquid hexavalent vaccine took approximately
50% less time than required to prepare the non-fully liquid vac-
cine (36 s vs. 70.5 s). Time savings were more pronounced among
less experienced HCPs (those performing less than 10 vaccinations
number of vaccination performed by HCPs in a week.
Number of vaccinationsa Total (N = 96)
icians (N = 50) GPs (N = 34) <10 (N = 42) ≥10 (N = 54)
.0) 10.1 (10.1) 12.9 (11.1) 20.4 (12.3) 17.2 (12.3)
2; 45 2; 45 2; 46 2; 46
.6) 8.7 (7.7) 5.2 (2.0) 24.5 (16.5) 16.1 (15.7)
2; 40 1; 9 10; 75 1; 75
.5) 6.7 (7.3) 4.4 (2.4) 23.7 (16.7) 15.3 (15.9)
1; 37 1; 9 5; 75 1; 75
.9) 3.6 (4.3) 2.6 (1.4) 13.5 (11.1) 8.8 (9.9)
1; 24 1; 5 2; 55 1; 55
3980 I. De Coster et al. / Vaccine 33 (2015) 3976–3982
Fig. 2. Mean time necessary to preparea the vaccine in total, by HCP specialty and by number of vaccinations performed in a week by HCPs. a Preparation time excluded time
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accinations performed by HCP in a week. Results are presented as mean ± 95% con
er week). Although time savings are expected to result in limited
ragmatic differences at individual HCP practice level, when mea-
ured over large cohorts of vaccinees (e.g. at a country level) time
avings can be signiﬁcant.
.2. Immunisation errors
Vaccination programmes seek high immunisation coverage
cross populations. The success of these programmes in protecting
ndividuals and society depends on a number of factors, including
he quality with which vaccines are administered [4]. Accord-
ng to the World Health Organization, adverse events following
mmunisation (AEFIs) due to programmatic errors in the stor-
ge, handling, or administration of vaccine are more common
han AEFIs due to the properties of vaccines [11]. Preparation of
he fully-liquid vaccine resulted in fewer immunisation errors as
ompared to the non-fully liquid vaccine since much more prepa-
ation steps are required with the latter. Although these results
re not unexpected, and gathered in experimental circumstances,
igniﬁcant differences are likely to occur in real life conditions.
rrors observed in this study during vaccine preparation could
e divided in two main categories: errors that could result in
ealth complications and errors reducing immunisation effective-
ess. Safety problems with vaccines requiring reconstitution have
een reported before [2]. During injecting drug preparation a vari-
ty of improper manipulations may  compromise sterility, resulting
n potential contamination of the end product [12]. A fully liquid
able 3
ime savings with a fully-liquid vaccine compared to a non-fully liquid vaccine in total, b
Specialty 
Nurses (N = 12) Paediatricians (N = 50) 
Time savingsb
Mean (SD) 37.8 (16.2) 25.6 (14.2) 
[95%  CI] [27.6; 48.1] [21.6; 29.7] 
Min;  Max  9; 63 −9; 66 
Wilcoxon paired test
p  <0.001 <0.001 
a Average number of vaccinations performed by HCPs in a week.
b Mean time needed to prepare non-fully liquid vaccine minus mean time needed to prge, needle(s), and documentation of vaccine administration. b Average number of
e intervals.
vaccine needing less manipulations will reduce this risk. Bundy
et al. proposed ‘the 5 rights’ of medicine administration (right
patient, right medication, right dosage, right time, right route) to
analyse reported vaccine errors [4,13,14]. Considering this, a fully
liquid one dose vaccine will offer fewer opportunities for error by
reducing the risk of wrong dosage as no contents have to be mixed
or aspired out of vials and therefore can avoid incomplete aspira-
tion or reconstitution failure. In this study 8 cases of incomplete
aspiration of the Hib vial, 1 leakage and 1 reconstitution failure
occurred, compromising as such a good immunisation. Compar-
ison can be made with iv drug administration, where multiple
step preparation, including reconstitution of a drug was identi-
ﬁed as one of the contributing factors for errors [15]. In addition,
the number of immunisation errors was higher in less experienced
HCPs. While enhanced training is one of the potential strategies
for reducing vaccination errors, the fact remains that depending of
the setting not every HCP has the opportunity to improve his or
her skills by practice: for instance, young HCPs with starting prac-
tices or settings where paediatric vaccination is less frequent. In
these cases particularly, fully liquid one dose vaccines will opti-
mise immunisation error reduction essential for patient safety and
vaccine effectiveness.
4.3. HCPs satisfaction and preferenceThe satisfaction perceived by HCPs with regard to the ease-
of-handling and the speed of preparation of both vaccines was
similar. Often, someone’s level of satisfaction is dependent on his
y HCP specialty and by number of vaccination performed by HCPs in a week.
Number of vaccinationsa Total (N = 96)
GPs (N = 34) <10 (N = 42) ≥10 (N = 54)
46.3 (44.1) 45.2 (38.8) 26.2 (17.1) 34.5 (30.0)
[30.9; 61.7] [33.1; 57.3] [21.5; 30.8] [28.4; 40.6]
−12; 195 −12; 195 −12; 105 −12; 195
<0.001 <0.001 <0.001 <0.001
epare fully liquid vaccine.
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Table  4
(a) Immunisation errors occurred during non-fully liquid and fully liquid vaccine preparation. (b) Immunisation errors during non-fully liquid and fully liquid vaccine
preparation: detailed information.
Immunisation errors (a)
Non-fully liquid Fully liquid
Number of immunisation errors per HCP Mean (SD) Min; Max  Mean (SD) Min; Max
Total  (N = 96) 0.5 (0.7) 0; 3 0.1 (0.3) 0; 1
Specialty
Nurse  (N = 12) 0.3 (0.5) 0; 1 0.3 (0.5) 0; 1
Paediatrician (N = 50) 0.5 (0.6) 0; 2 0.1 (0.3) 0; 1
GP  (N = 34) 0.6 (0.8) 0; 3 0.1 (0.2) 0; 1
Number of vaccines administereda
<10 (N = 47) 0.6 (0.7) 0; 2 0.1 (0.4) 0; 1
≥10  (N = 54) 0.4 (0.7) 0; 3 0.1 (0.3) 0; 1
Type  of immunisation errors (N = 96) n (%) n (%)
No purge by the end of preparation 12 (12.5) 4 (4.2)
Purge  performed before using the second needle 11 (11.5) 2 (2.1)
Non-fully liquid vaccine prepared using only one needle 8 (8.3) –
Whole content of the vial not aspired into the syringe 8 (8.3) –
Other 8 (8.3) 4 (4.2)
Total  number of immunisation errors (n) 47 10
Immunisation errors (b)
Non-fully liquid (N = 96) Fully liquid (N = 96) Total (N = 192)
Immunisation errors as deﬁned in the protocol n (%) n (%) n (%)
HCP  ﬁngers touched the vial rubber cap after removal of the protective plastic cap 2 (2.1%) 0 (0.0%) 2 (1.0%)
HCP  ﬁngers touched the top of the syringe after removal of the protective cap 0 (0.0%) 0 (0.0%) 0 (0.0%)
HCP  ﬁngers touched sterile part of the needle used for reconstitution or injection 1 (1.0%) 1 (1.0%) 2 (1.0%)
Liquid  leakage during preparation 1 (1.0%) 0 (0.0%) 1 (0.5%)
Haemophilus inﬂuenza type B (Hib) reconstitution missed 1 (1.0%) 0 (0.0%) 1 (0.5%)
Syringe has not been purged by the end of the preparation process 12 (12.5%) 4 (4.2%) 16 (8.3%)
Needle  stick during vaccine preparation 0 (0.0%) 0 (0.0%) 0 (0.0%)
Prepared using one needle only 8 (8.3%) 0 (0.0%) 8 (4.2%)
HCP  did not aspire the whole content of Hib vial in the syringe 8 (8.3%) 0 (0.0%) 8 (4.2%)
Other  observed immunisation errors n (%) n (%) n (%)
Changed the needle before drawing up the liquid- 2 needles were used but the same needle
was  used for reconstitution and injection
1 (1.0%) 0 (0.0%) 1 (0.5%)
HCP  recapped the syringe with a rubber that touched the tray–Purged 2 times but not at the
end- Needle changed 3 times
0 (0.0%) 1 (1.0%) 1 (0.5%)
Purge  performed before using the second needle 11 (11.5%) 2 (2.1%) 13 (6.8%)
Purge  performed before assembling needle and syringe 0 (0.0%) 2 (2.1%) 2 (1.0%)
Syringe was  put down on the tray–risk of contamination at the tip 1 (1.0%) 0 (0.0%) 1 (0.5%)
The  needle twisted when it was inserted in the vial stopper 1 (1.0%) 0 (0.0%) 1 (0.5%)
“ “n” is 
o
e
i
f
k
v
v
t
p
4
t
a
w
e
n
i
f
c
HN” is the number of vaccine preparations performed for each form of the vaccine. 
ccur  during fully liquid vaccine preparation.
a Average number of vaccines administered by HCPs in a week.
xpectations. The two vaccines have different characteristics and
t is reasonable to consider that HCPs had different expectations
or each vaccine, especially for a vaccine that is new on the mar-
et. However, almost all HCPs would prefer using the hexavalent
accine in their childhood vaccination daily practice as fully-liquid
accine in preﬁlled syringe. Even though preference is subjective,
he involvement of participating HCPs in the whole vaccination
rocess lends credibility to the preference they expressed.
.4. Limitations of the study and external validity of the ﬁndings
Although this study was conducted in only one European coun-
ry, it can be assumed that childhood vaccine preparation practices
re similar from one country to another. Therefore, time savings
ith the fully-liquid vaccine highlighted in this study can be gen-
ralised to other countries (i.e. a 50% reduction in comparison to the
on-fully liquid vaccine). There are, however, possible differences
n local practices, cultural preferences for speciﬁc pharmaceutical
orms and also speciﬁc organisation of vaccine delivery in other
ountries, which may  impact the generalisation of preference of
CPs for the fully-liquid vaccine.the number of immunisation errors observed. “–” Type of mishandling that cannot
5. Conclusions
Fully-liquid hexavalent vaccine reduced signiﬁcantly the prepa-
ration time as compared to non-fully liquid hexavalent vaccine that
needs more steps for reconstitution of the vaccine. This can have
signiﬁcant impact when considering large number of vaccination
processes. Lastly, reducing steps in the vaccine preparation work-
ﬂow decreases the opportunities for immunisation errors and thus
might impact safety.
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